
FDA’s New Medical Robotics Discussion Paper: Why Cybersecurity Must Be Evaluated End to End.
FDA’s new discussion paper on medical robotics carries one message cybersecurity teams should not miss: risk cannot be assessed one component at a time. On
" " indicates required fields

FDA’s new discussion paper on medical robotics carries one message cybersecurity teams should not miss: risk cannot be assessed one component at a time. On

What Changes When Your Devices Are Already in the Field By Ken Zalevsky, VP and GM, C2A Security A revision would likely do more than

Jerusalem, Israel, August 25, 2026 — C2A Security, the only context and AI-driven product security orchestration platform addressing the needs of software-defined products and cyber-physical

Five agencies, the Siemens S7 advisory, and the product security question underneath it On August 19, 2026, five U.S. federal agencies signed the same document.

Lubadel brings more than 25 years of healthcare technology, product security and regulatory experience to support C2A Security’s strategy across medical devices and other cyber-physical

The future belongs to systems that can prove provenance, context and chain of custody. The Growing Challenge of Digital Trust Artificial intelligence is changing the

John brings extensive automotive, OEM, supplier, and cybersecurity leadership experience from companies like Porsche, Volkswagen, and Rivian to help shape C2A Security’s roadmap across multiple

Following a Successful Proof of Concept, Triumph Commits to the Long-Term Deployment of the EVSec Platform Across Its Product Security Lifecycle JERUSALEM, Israel, July 28,

C2A Security · July 2026 · 10 min read Executive Summary Cybersecurity is no longer measured solely by an organization’s ability to prevent vulnerabilities. Increasingly, regulators, customers, and